Proficio Capital Partners LLC bought a new position in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 14,748 shares of the specialty chemicals company's stock, valued at approximately $1,623,000. Proficio Capital Partners LLC owned 0.06% of Innospec as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of IOSP. New York State Teachers Retirement System lifted its holdings in Innospec by 2.6% in the third quarter. New York State Teachers Retirement System now owns 14,781 shares of the specialty chemicals company's stock valued at $1,672,000 after acquiring an additional 371 shares during the period. US Bancorp DE lifted its holdings in Innospec by 323.6% in the third quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company's stock valued at $621,000 after acquiring an additional 4,194 shares during the period. Leeward Investments LLC MA lifted its holdings in Innospec by 22.4% in the third quarter. Leeward Investments LLC MA now owns 86,004 shares of the specialty chemicals company's stock valued at $9,726,000 after acquiring an additional 15,750 shares during the period. Crossmark Global Holdings Inc. lifted its holdings in Innospec by 23.7% in the third quarter. Crossmark Global Holdings Inc. now owns 2,286 shares of the specialty chemicals company's stock valued at $258,000 after acquiring an additional 438 shares during the period. Finally, State of New Jersey Common Pension Fund D lifted its holdings in Innospec by 17.8% in the third quarter. State of New Jersey Common Pension Fund D now owns 17,409 shares of the specialty chemicals company's stock valued at $1,969,000 after acquiring an additional 2,625 shares during the period. Institutional investors and hedge funds own 96.64% of the company's stock.
Innospec Price Performance
NASDAQ:IOSP traded up $1.08 during trading hours on Friday, reaching $100.62. The company had a trading volume of 176,607 shares, compared to its average volume of 149,289. The firm has a market cap of $2.51 billion, a PE ratio of 70.86 and a beta of 1.08. The business's 50 day moving average price is $108.89 and its 200-day moving average price is $111.94. Innospec Inc. has a 1-year low of $97.13 and a 1-year high of $133.71.
Innospec (NASDAQ:IOSP - Get Free Report) last announced its earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.05. The business had revenue of $466.80 million during the quarter, compared to the consensus estimate of $447.43 million. Innospec had a return on equity of 12.27% and a net margin of 1.93%. On average, analysts expect that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.
Insider Transactions at Innospec
In other news, SVP Corbin Barnes sold 598 shares of the company's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $103.06, for a total transaction of $61,629.88. Following the completion of the transaction, the senior vice president now directly owns 8,051 shares of the company's stock, valued at $829,736.06. This represents a 6.91 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Milton C. Blackmore sold 652 shares of the company's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $103.30, for a total value of $67,351.60. Following the transaction, the director now directly owns 8,376 shares of the company's stock, valued at approximately $865,240.80. The trade was a 7.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,696 shares of company stock valued at $794,853 in the last three months. 1.52% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Separately, StockNews.com raised Innospec from a "hold" rating to a "buy" rating in a report on Thursday.
Get Our Latest Analysis on Innospec
About Innospec
(
Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Further Reading
Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
